PENNYBUSTER'S PENNY BUSTIN PLAYS!!

[Pennybuster]

Medican Inc. is seeking to acquire a 50% stake in IHMML, which is acquiring two facilities at 393,000sqft. and 293,000sqft that will be able to extend to 900,000 sqft.
Medican Inc. represents one of the strongest "speculative" Canadian plays for investors in the US.
The Canadian marijuana market may have been grossly underestimated with a potential market capitalization of $2-4 billion.
A new organization called the Canadian National Medical Marijuana Association (CNMMA) has stamped Medican with approval along with IHL and Zenabis.
In the Canadian marijuana market: size matters. Even the darling of the marijuana market (Tweed) will seem pint size next to Medican.

Over the past month, several publicly traded companies jumping in on the "Canadian Cannabis Craze" have caught our attention: Enertopia (OTCQB:ENRT), Creative Edge Nutrition (OTCPK:FITX), Next Gen Metals (OTCPK:NXTTF), Abattis Bioceuticals (OTCPK:ATTBF), and Modern Mobility Aids (OTCPK:MDRM). There is one restless giant, however, that has not had its fair share of the spotlight. And boy, does it need it.

Medican Inc. (OTCQB:MDCN): A Giant in our Midst

If you have been paying attention to headlines coming out of Canada, you would have heard about a company called "Zenabis" and their plan to acquire a 393,000 square foot facility for medical marijuana production. News like this makes investors drool. I briefly discussed this company in a previous article. What I didn't mention was that the company behind this acquisition has been Medican Enterprises. Medican might be the most ambitious player in the Canadian scene. If it succeeds, a few years from now investors will say, "Tweed who?"

The story begins last year on June 25, 2013. Kenneth Williams, a veteran of Michigan's Medical Marijuana Program, bought out a Nevada based shell, TC X Calibur Inc., for the very purpose of running a publicly traded Canadian MMPR firm. From this moment on, Mr. Williams has worked tirelessly to assemble an experienced team, accrue essential assets, and form strategic partnerships in order to create a medical marijuana empire.

The story is impressive. But investors should be forewarned: the only tangible asset that Medican can boast is ownership of Cannabis Magazine. The company publishes Cannabis Magazine online and in hard copy form, which is distributed for free in over 4000 medical cannabis locations throughout the United States. Nevertheless, I still think there is strong evidence to be bullish.

Team: The Marijuana Aficionados

Medican boasts one of the most impressive teams of any of the publicly traded Canadian marijuana companies.

Board of Directors

The honorable Gary Johnson, two-term governor of New Mexico, serves as a director of Medican Inc. In addition to starting a successful multimillion-dollar enterprise, the honorable libertarian has been a longtime advocate for marijuana legalization. You may remember Gary Johnson as the 2012 libertarian presidential candidate who won .99% of the vote.
Michael Thompson has been involved in the medical marijuana industry as a licensed provider since early 2012.

Management

Kris Klassen President. According to his bio, Mr. Klassen has "over 15 years experience in the medical marijuana industry." Disclaimer: this information is unverifiable.
Wayne Hansen CFO
Bal Sandu, P. Eng., COO.
Danny Camele, VP Marketing

Research and Development

Laila Benkrima, Ph.D, is Medican's chief horticulturalist. Dr. Benkrima is an expert in chemical hybridizing agents in wheat. Dr. Benkrima is not an expert in medical marijuana. She is currently a research associate at BCIT in the Natural Health & Food Products Research Center for Applied Research and Innovation.
Renee Priya Prasad, Ph.D, Sr. Production Manager. Dr. Prasad is a specialist in pest control. Again, it is important to note that Dr. Prasad is not an expert in marijuana pest control. Dr. Prasad is a highly experienced entomologist with over 18 years of experience in cranberry crop control.
Manessha Jaitly, Ph.D., Quality Assurance Manager

Although a very knowledgeable team, it is questionable that these scientists are agreeing to apply their expertise to marijuana cultivation. Dr. Benkrima is a "wheat" specialist; Dr. Prasad is a "cranberry" specialist. As I am not an expert in any of the related fields, I do not know whether the fields are that different and that the R&D team will be unable to apply their horticultural expertise to medical marijuana.

Advisory Board

David Tobias, founder of Hemp Inc. and Cannabis Sativa Inc.
Rick Brar, President and CEO of IHL
Kevin Coft, General Manager at IHL
Sam Perera, MBA, CAIA Founding partner at Lion Financial Group (LFG)

Some investors might be uncomfortable with the name David Tobias attached to the firm. However, I am fairly confident that he will benefit Medican immensely since he does have extensive experience in the field of publicly traded marijuana stocks.

It is clear that Mr. Williams has put together a distinguished team. Most of the Medican team boasts years of experience in the business of marijuana cultivation, production, and sales. This is the kind of team I feel comfortable investing in.



http://seekingalpha.com/article/2131563-canadian-marijuana-stocks-medican-and-ihmml-give-investors-a-reason-to-be-bullish